Omni Louisville Hotel
400 S. 2 nd Street
Louisville, KY 40202
The 2020 ASPC Abstract Committee invites the submission of abstracts to be presented at the 2020 Congress on Cardiovascular Disease Prevention July 24-26, 2020, at Omni Louisville Hotel in Louisville, KY. Submitted abstracts will be considered for the poster hall and the top three Early Career abstracts with be picked for an oral presentation during the abstract session at the meeting.
All abstracts must be submitted online via the ASPC abstract submission website using the online submission form. Please be sure to read all instructions, information, and policies closely.
Abstract Submission Deadline
Friday, April 3, 2020
5:00 p.m. EST
Abstract Acceptance Notification
Friday, April 24th , 2020
Presenting Author Registration Deadline for CVD Prevention Conference
Friday, May 29, 2020
Registration will be complimentary to the 2020 ASPC Congress on CVD Prevention for the Presenting Author
ASPC Early Career Awards
Early Career (in training students, residents, and fellows or members in practice for <5 years) will have the chance to compete for the ASPC’s Early Career Research Award Cash prizes of $750, $500, and $250 will be presented to the top three Early Career Research Award Winners In addition, the top three Early Career Research Awards Winners with be selected for an oral presentation. Presenting Authors submitting for the Early Career Award must upload a CV with their submission.
If you are the recipient of one of our Early Career Research Award, you are required to register and attend the 2020 Congress on Cardiovascular Disease Prevention, as well as attend all abstract-related responsibilities. These responsibilities include hanging your Abstract in the Poster Hall, standing by your poster in the poster hall during the Question and Answer Designated, as well as attend the oral presentation session. If you fail to attend these events, your prize and travel money could be revoked.
All accepted abstracts will be displayed in the Abstract Poster Hall and have designated times for Author Q&A sessions.
The ASPC Abstract Committee will select three Early Career Abstracts to be presented during the oral abstract session on Saturday, July 25, 2020. Authors will have 15-minutes to present their research (7-
10-minutes to present and 5-7-minutes for questions and answers).
Abstract Submission Instructions
Please read through the submission instructions below before preparing your abstract:
- Read the General Information and Policies for the submission of an abstract.
- Write your abstract, following the Abstract Guidelines.
- Select a Topic that best relates to your abstract.
- Review the Acceptance and Presentation Process for abstracts.
- Submit your abstract through the Online Abstract Submission Form.
- Register to attend the 2020 Congress on Cardiovascular Disease Prevention (ASPC staff will contact you with a complimentary meeting registration code for the presenting author only to register for the meeting after your abstract has been accepted).
General Information and Policies
- As you will see, there will be a point in the process when you MUST finalize your abstract and make a FINAL submission. Please note that if you do not mark your abstract as complete and make a FINAL submission, it will NOT be considered. Take note of any deadlines under the appropriate call for abstracts and be sure to complete the process before that date.
- Do not CREATE your abstract in the submission system, but rather create your abstract in a separate Word document and COPY and PASTE it into the abstract submission system. This way,
you will not have lost your abstract in the event of disconnection from the Internet, etc. Be sure to check for errors when pasting. Certain special characters may be changed by the browser.
- If you are currently a member of the ASPC, we will prefill your address information for you in the online submission form based on your current aspconline.org account information profile. Note that changes made here will apply to your abstract only and WILL NOT BE APPLIED to your ASPC member record or aspconline.org account.
- The presenting author must register for the 2020 Congress on Cardiovascular Disease Prevention to ensure his or her abstract(s) are included in onsite materials. Deadline for author registration is Friday, May 29, 2020. Lead authors MUST BE registrants at the ASPC Congress on Cardiovascular Disease Prevention. If your abstracted is accepted, the presenting author will receive a code for a complimentary registration for the 2020 ASPC Congress on CVD Prevention.
- To submit an abstract, all the authors listed on the abstract must approve the final version. In addition, each author listed on the abstract should have made a substantial contribution to it, such as 1) contributing to the conception and design of the study and the acquisition of data; 2) analysis and interpretation of the data; and/or 3) drafting the poster and/or revising it critically for important intellectual content. Full disclosures must be provided for each author. These requirements are taken seriously by ASPC and any failure to fully comply with these requirements may result in an abstract being withdrawn from the ASPC abstracts program.
- It is the responsibility of the lead author to ensure that his or her abstract is submitted correctly.
- Abstracts will be reviewed by the appointed ASPC Abstracts Review Committee Member.
- Faxed, emailed or mailed hard-copy abstracts or abstracts sent on a CD/disc WILL NOT be accepted. If you are unable to submit via the website, please contact the ASPC Annual Meeting Staff:
Contact: Maggie Kincaid
The ASPC will not be responsible for abstract submissions not received via the website or for submission errors caused by Internet service outages, hardware or software delays, power outages, or unforeseen events.
Abstracts for poster entries submitted for competition can only be accepted electronically and must adhere to the following guidelines:
- Abstracts are limited to 350 words. (Word count excludes the abstract title, author names, and affiliations.)
- Abstracts must be divided into sections: Title, Background, Methods, Results, and Conclusion that states the importance and potential implications of the observations.
- Abstracts must be proofread carefully to avoid errors before submission.
- Abstracts must contain generic drug names only.
- Abstracts must be submitted in clear English with accurate grammar and spelling of a quality suitable for publication.
- All authors must disclose all relevant financial relationships.
- Any funding support for the research must be disclosed.
- The main research findings should not have been presented at another major scientific meeting prior to presentation at the ASPC Sessions.
The purpose of the abstract is to define the precise subject of the presentation to an audience. Below you will find a checklist for abstract preparation. All abstracts are considered equally for selection, and the quality of the abstract is the single most important factor in the Committee’s decision.
You will be asked for the following:
- Background – A concise description of your subject matter and prior work in this area.
- Methods - The experimental design or technique employed.
- Results - Outcomes & measurements, with statistical significance, if appropriate
- Conclusion - Conclusions, clinical pertinence, and value or for Workshops and Presentations, the prevailing point of view.
- Authors - For each author you must provide first and last name, city and state as well as preliminary financial disclosure information. If you would like to be considered for Early Career Research Award, the Primary/Presenting Author should also upload a brief paragraph describing their qualifications in the chosen subject area and/or a CV.
- Tables and Figures – Upload a table or figure that show results related to your research.
Abstract Submission Topics
To ensure your abstract receives proper consideration, the abstract must relate to an appropriate topic in the field of Cardiology and cardiovascular disease prevention. Abstract authors will be required to indicate which topic BEST matches the content of their abstract. Topics for the 2020 ASPC Congress on Cardiovascular Disease Prevention are:
- ASCVD/CVD Risk Factors
- ASCVD/CVD Risk Assessment
- ASCVD /CVD Risk Reduction
- CVD Prevention – Primary and Secondary
- Preventive Cardiology Best Practices – clinic operations, team approaches, outcomes research
- Metabolic Syndrome
- Kidney Disease
- Novel Biomarkers
- Pharmacologic Therapy
- ASCD/CVD in Women
- ASCVD/CVD in Special Populations
- Heart Failure
- Ischemic Stroke
- Peripheral Artery Disease
- Alterative and Complimentary Approaches
If you do not see an appropriate topic listed above that best relates to your abstract, please contact the ASPC office at email@example.com or call 904-233-0282.
Acceptance and Presentation Process
Abstract grading is blinded, and abstracts are pre-screened and selected by ASPC judges based on quality and merit. You will be notified no later than Friday, April 24, 2020. if your poster is accepted. All presenting poster authors are required to register for the 2020 Congress on Cardiovascular Disease Prevention July 24-26, 2020, at Omni Louisville Hotel in Louisville, KY to participate in all abstract author events. Presenting Authors will receive a registration code for complimentary registration to the 2020 ASPC Congress on CVD Prevention.
*Expenses related to airfare, lodging, and social events/guest fees are the responsibility of the presenter. Special programs may be available for trainees, fellows, and Early Career.
ASPC is offering 3 travel grants to trainees, fellows, or early career to attend the ASPC 2020 Congress on CVD Prevention. For more information please contact Maggie Kincaid at Mkinciad@aspconline.org.
Poster guidelines will be provided to lead authors by May 1, 2020.
Friday, July 24, 2020
|3:30 PM – 3:40 PM||Welcome|
|3:40 PM – 3:45 PM||Audience Response Questions|
|3:45 PM – 4:10 PM||Introduction by Louisville’s Mayor’s Office|
|4:10 PM – 4:35 PM||Keynote Lecture: Novel Insights Into The Cardiovascular Health of African Americans Based on the Jackson Heart Study
Herman Taylor, MD, MPH
|4:35 PM – 5:00 PM||Leaders in Medicine Lecture
Arthur Agatston, MD
|5:00 PM – 5:30 PM||Question and Answer Panel Discussion and Audience Response Questions|
|5:30 PM – 6:30 PM||Welcome Reception with Exhibitors|
Saturday, July 25, 2020
|7:00 AM – 7:50 AM||Breakfast with Exhibitors / Poster Review|
|7:50 AM – 8:00 AM||Welcome and Audience Response Questions|
|8:00 AM – 8:25 AM||Why Has There Been Such Resistance to ApoB in the US and What Can Be Done?
Allan Sniderman, MD
|8:25 AM – 8:50 AM||NASH and CVD
Seth Baum, MD, FASPC
|8:50 AM – 9:15 AM||Atherosclerosis and MicroRNA’s
Peter Toth, MD, PhD, FASPC
|9:15 AM – 9:40 AM||Question and Answer Panel Discussion and Audience Response Questions|
|9:40 AM – 9:55 AM||Refreshment Break|
|SESSION 3||HONORARY FELLOWSHIP AWARD AND LECTURE|
|9:55 AM – 10:00 AM||Presentation of Honorary Fellowship Award|
|10:00 AM – 10:25 AM||Honorary Fellowship Lecture: Transforming Cardiovascular Prevention for Women: Time for the Pygmalion Construct to End
Nanette Wenger, MD, FASPC
|10:25 AM – 10:35 AM||Question and Answer Discussion|
|SESSION 4||EARLY CAREER RESEARCH AWARDS AND PRESENTATIONS|
|10:35 AM – 10:40 AM||Introductions|
|10:40 AM – 10:55 AM||Early Career Research Presentation|
|10:55 AM – 11:10 AM||Early Career Research Presentation|
|11:10 AM – 11:25 AM||Early Career Research Presentation|
|11:25 AM – 11:35 AM||ASPC Business Meeting|
|11:35 AM – 12:30 PM||Lunch with Exhibitors / Poster Review|
|12:30 PM – 12:35 PM||Audience Response Questions|
|12:35 PM – 1:00 PM||ISCHEMIA Trial – Lessons Learned and Lessons Applied
David Maron, MD, FASPC
|1:00 PM – 1:25 PM||Newer Insights into Accessing Risk in Hispanic Patients
Ileana Pina, MD
|1:25 PM – 1:50 PM||Poly Pill and Other Innovative Approaches to Risk Factor Management
Keith Ferdinand, MD, FASPC
|1:50 PM – 2:15 PM||Audience Response Question and Question and Answer Panel Discussion|
|2:15 PM – 2:30 PM||Break|
|SESSION 6||Nanette Wenger Award and Lecture|
|2:30 PM – 2:35 PM||Introduction of Award|
|2:35 PM – 3:00 PM||Nanette Wenger Award Lecture: Is There a Sex-specific Phenotype for Atherosclerotic Plaque?
Leslee Shaw, PhD
|3:00 PM – 3:10 PM||Question and Answer Session|
|SESSION 7||CVD Prevention in The Lifespan of Women|
|3:10 PM – 3:15 PM||Audience Response Questions|
|3:15 PM – 3:40 PM||Coronary Microvascular Dysfunction in Women
Vivian Tacheti, MD
|3:40 PM – 4:05 PM||Adverse Pregnancy Outcomes and CVD Risk
Renee-Bullock Palmer, MD
|4:05 PM – 4:30 PM||Menopause and Its Impact on Women’s Cardiovascular Health
Erin Michos, MD, MHS, FASPC
|4:30 PM – 4:55 PM||Audience Response and Question and Answer Session|
|SESSION 8||Prevention Cases|
|4:55 PM – 5:10 PM||Case Study|
|5:10 PM – 5:25 PM||Case Study|
|5:25 PM – 5:40 PM||Case Study|
|5:40 PM – 5:55 PM||Question and Answer Session|
Sunday, July 26, 2020
|8:00 AM – 8:05 AM||Audience Response Questions|
|8:10 AM – 8:35 AM||Statin Usage in Athletes – Problematic or Problem Free?
Paul Thompson, MD
|8:35 AM – 9:00 AM||Heart Failure with Preserved Ejection Fraction – What’s New and Can We Prevent?
Douglas Schocken, MD, FASPC
|9:00 AM – 9:25 AM||Genetic Testing in Preventive Cardiology – How To, And What Do We Know?
Amit Khera, MD, MSc, FASPC and Amit V. Khera, MD, MSc
|9:25 AM – 9:50 AM||Audience Response and Question and Answer Session|
|9:50 AM – 9:55 AM||Audience Response Questions|
|9:55 AM – 10:35 AM||Stokes Award Lecture
Paul Ridker, MD
|10:35 AM – 11:00 AM||Overcoming Racial/Ethnic Disparities in Clinical Research and Care: Present and Emerging Solutions
|11:00 AM – 11:25 AM||Million Hearts – Moving the Prevention Needle for The Population
Laurence Sperling, MD, FASPC
|11:25 AM – 11:55 AM||SCCT Debate: Imaging and Prevention – CTA Vs. CAC
Khurram Nasir, MD, MPH, MSc, FASPC and James Min, MD